Marc Scheineson comments on the Food & Drug Administration’s approach to regulating medical apps.
In the News
August 24, 2018
BioWorld, FDA Week, Inside Health Policy, Medtech Insight | Liability for Devices without Predicates is ‘Unexplored Territory’
Media Contact